Navigation Links
Paul Capital Healthcare Purchases Additional Royalty Interest in GlaxoSmithKline's Rotarix(R)
Date:1/23/2008

Fund's Third Investment in Vaccine to Prevent Rotavirus

NEW YORK, Jan. 23 /PRNewswire/ -- Paul Capital Healthcare today announced that it has purchased a royalty interest in Rotarix(R) from Cincinnati Children's Hospital Medical Center. Rotarix(R) is an oral vaccine developed to prevent rotavirus infection, a contagious viral disease that causes diarrhea and dehydration in infants and young children. The product is marketed by GlaxoSmithKline (GSK) and has been approved in over 100 countries including all of Europe, most of Latin America, and much of Asia, Africa and the Middle East.

Under the terms of this agreement, Paul Capital Healthcare acquired all royalties on worldwide sales of Rotarix(R) from Cincinnati Children's. This is the third investment that the Fund has completed related to Rotarix(R) royalties. In November 2005, Paul Capital Healthcare acquired an interest in Rotarix(R) from three inventors at Cincinnati Children's; and in May 2005 acquired a portion of AVANT Immunotherapeutics' total royalties on Rotarix(R).

"Rotavirus is a serious condition that impacts millions of infants and young children worldwide, leading to fatalities in many cases. We believe that Rotarix(R) addresses a critical global health need and are confident in the long-term viability of the product," said Dr. Walter Flamenbaum, Partner, Paul Capital Healthcare.

Rotarix(R) was invented and initially developed by researchers now at Cincinnati Children's. In 1995, AVANT in-licensed the Rotarix(R) technology from Cincinnati Children's. GSK subsequently licensed the product from AVANT in 1999. According to GSK, rotavirus infects virtually every child worldwide by age five and is the leading cause of severe acute gastroenteritis in infants and young children worldwide. Severe diarrhea and dehydration occurs in infants as young as three months of age with peak incidence between six months and two years.

About Paul Capital Partners and Paul Capital Healthcare

Paul Capital Partners manages nearly $5 billion in equity capital commitments for its three investment platforms that include healthcare direct investments (including royalty and revenue interests in healthcare products), Private Equity Secondaries and Top Tier Fund-of-Funds. The firm has offices in New York, San Francisco, Paris, London and Toronto. Paul Capital Healthcare is one of the largest dedicated healthcare funds globally, with $1.8 billion in equity capital commitments and debt facilities under management. Paul Capital Healthcare has invested more than $875 million in the pharmaceutical, biotechnology, and medical device sectors. These investments are focused on commercial stage companies and products, and consist of investments in the form of royalties, revenue interests, debt and equity. For more information, visit http://www.paulcapitalhealthcare.com.

Contacts:

Fern Lazar

Lazar Partners

212-867-1765

flazar@lazarpartners.com


'/>"/>
SOURCE Paul Capital Healthcare
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Replidyne to Participate on Anti-infective Panel at RBC Capital Markets Healthcare Conference
2. Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
3. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
4. Siemens Healthcare Diagnostics Launches B12, Folate, and Ferritin Tests on Its Dimension vista Intelligent Lab System
5. Idenix Pharmaceuticals Provides Update on Hepatitis C Pipeline at JP Morgan Healthcare Conference
6. Amicus Therapeutics to Present at the 26th Annual JPMorgan Healthcare Conference
7. Survey Finds U.S. Healthcare Facilities Not Doing Enough to Curb MRSA
8. GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution
9. BD to Present at Investor Healthcare Conferences
10. Inverness Medical Innovations to Present at CIBC World Markets 18th Annual Healthcare Conference on November 7, 2007
11. Immtech to Present at The Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... to their offering. The ... commercial environment for MedImmune to enter. The US ageing population ... to drive considerable growth for effective anti-influenza medications. The introduction ... considerably, but development is still in its infancy. ...
(Date:6/23/2016)... 23, 2016 Revolutionary technology includes ... Oticon , industry leaders in advanced audiology and hearing ... Oticon Opn ™, the world,s first internet connected hearing ... IoT devices.      (Photo: http://photos.prnewswire.com/prnh/20160622/382240 ... number of ,world firsts,: , TwinLink™ - ...
Breaking Medicine Technology:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Pixel Film ... Pro X. , "Film editors can give their videos a whole new perspective by ... Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 ...
(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... Lewisville, TX (PRWEB) , ... June 25, 2016 , ... ... in the United States, named Dr. Sesan Ogunleye, as the Medical Director of its ... be the facility Medical Director of our new Mesquite location,” said Dr. James M. ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of ... too high can result in disappointment, perhaps even self-loathing. However, those who set the ... Research from PsychTests.com reveals that behind the tendency to set low expectations ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her son ... lash out at his family verbally and physically. , “When something upset him, he couldn’t ... would use it. He would throw rocks at my other children and say he was ...
Breaking Medicine News(10 mins):